SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-21-062855
Filing Date
2021-12-01
Accepted
2021-12-01 16:43:56
Documents
20

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b31121_cmlifesci3.htm 424B3 14697165
2 GRAPHIC teqrx_logo.jpg GRAPHIC 702720
3 GRAPHIC teqrxstand_001.jpg GRAPHIC 1004746
4 GRAPHIC tmission_001.jpg GRAPHIC 1420356
5 GRAPHIC tglance_001.jpg GRAPHIC 1484773
6 GRAPHIC tletter_001.jpg GRAPHIC 197583
7 GRAPHIC timage_021.jpg GRAPHIC 382158
8 GRAPHIC timage_002.jpg GRAPHIC 605466
9 GRAPHIC timage_003.jpg GRAPHIC 585535
10 GRAPHIC timage_004.jpg GRAPHIC 503201
11 GRAPHIC timage_005.jpg GRAPHIC 2184803
12 GRAPHIC timage_006.jpg GRAPHIC 518500
13 GRAPHIC timage_007.jpg GRAPHIC 452546
14 GRAPHIC timage_022.jpg GRAPHIC 630693
15 GRAPHIC timage_009.jpg GRAPHIC 451082
16 GRAPHIC timage_010.jpg GRAPHIC 629346
17 GRAPHIC timage_011.jpg GRAPHIC 600409
18 GRAPHIC timage_012.jpg GRAPHIC 588564
19 GRAPHIC teqrx_logored.jpg GRAPHIC 706221
20 GRAPHIC teqrx_red.jpg GRAPHIC 679639
  Complete submission text file 0001213900-21-062855.txt   34436318
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-259054 | Film No.: 211463547
SIC: 2834 Pharmaceutical Preparations